Trans-auricular vagus nerve stimulation plus robotic or traditional arm rehab for recovery after subacute stroke
Official title: Effects of Trans-Auricular Vagal Stimulation on Neuromotor Recovery Post-Stroke in the Subacute Phase During Training With the Khymeia Technological Device and Traditional Rehabilitation
Run by Istituti Clinici Scientifici Maugeri SpA · NCT07254390 · Data updated 2026-11-12
This pilot tests whether gentle ear (trans-auricular) vagus-nerve stimulation added to robotic or usual arm therapy helps people recovering from a recent stroke regain upper-limb movement.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 48 (estimated) |
| Sponsor | Istituti Clinici Scientifici Maugeri SpA Academic / other |
| Locations | 1 site (Montescano, Pavia) |
| Status | Recruiting |
| Started | January 8, 2025 |
| Main results expected | December 20, 2026 |
| Study ends | April 3, 2027 |
| Registry record updated | May 12, 2026 |
| Trial ID | NCT07254390 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) with a single cortical or subcortical ischemic or hemorrhagic stroke within the previous six months causing hemiplegia, with some preserved ability to follow instructions, a submaximal Motricity Index, and spasticity no greater than Modified Ashworth Scale 2 are ideal candidates.
✕Probably not a fit
Patients with multiple brain lesions, severe spasticity (MAS 3–4), aphasia or cognitive/behavioral problems that prevent participation, orthopedic limitations, or who cannot attend intensive daily rehab are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized pilot allocates subacute stroke patients admitted for intensive rehabilitation to four groups combining either active or sham trans-auricular vagus nerve stimulation (tVNS) with either traditional or Khymeia robotic upper-limb training. tVNS is delivered with the Parasym® device to the left ear for 60 minutes daily during the rehabilitation period. The primary outcome is change in upper-limb motor function measured by the Fugl-Meyer scale, with secondary outcomes including other clinical, cognitive, psychological, neurophysiological, and autonomic measures. The trial targets adults within six months of a single ischemic or hemorrhagic stroke who can follow instructions and provide informed consent.
Why it matters
Potential benefit: If successful, adding noninvasive ear vagus stimulation could speed or strengthen recovery of arm movement when paired with standard rehabilitation.
How similar studies have gone: Implanted vagus nerve stimulation paired with training has shown encouraging results in prior trials, while noninvasive transcutaneous/auricular VNS remains less established but supported by small, preliminary studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with hemiplegia following ischemic or hemorrhagic stroke occurred within the previous 6 months, clinically stable * Age ≥ 18 years * Single cortical or subcortical lesion documented on neuroimaging, corresponding to the motor deficit * Cognitively able to understand and follow therapeutic instructions * Upper limb weakness confirmed by a Motricity Index score below maximum * Spasticity, if present, compatible with limb function (Modified Ashworth Scale ≤ 2) * Written informed consent provided Exclusion Criteria: * Multiple brain lesions on neuroimaging * Severe spasticity (Modified Ashworth Scale 3-4) * Aphasia preventing comprehension of verbal instructions * Cognitive decline or behavioral disorders interfering with collaboration during training * Orthopedic conditions or surgical outcomes preventing the execution of the rehabilitation training
Where it's running
-
ICS Maugeri - Montescano
Montescano, Pavia, Italy Recruiting
Study contacts
- Study coordinator: Cira Fundaro'
- Email: cira.fundaro@icsmaugeri.it
- Phone: 0385247268
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Deep phenotyping to explore recovery in young adults after stroke
This project will test whether a detailed health and sample-collection approach (deep phenotyping) is practical and acceptable for people aged 18–55 who have had a stroke.
-
Stem cell therapy for chronic stroke recovery
This study is testing whether using a patient's own stem cells can help people with long-term stroke recovery feel better and improve their daily functioning.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Web-based therapy using action observation and mirror therapy for arm weakness after stroke
This trial tests whether a mobile telerehabilitation app delivering action observation therapy (AOT) alone or combined AOT with mirror therapy (AOT-MT) can improve upper limb function in people with subacute stroke.
-
Remote Ischaemic Conditioning for Fatigue After Stroke 2
Aat least 12 weeks after stroke, adults with post-stroke fatigue will try a simple hand-arm cuff treatment at home to see if it helps reduce fatigue.
-
Dual-task balance training plus computer-based cognitive training after stroke
In adults who recently had a stroke, the study tests whether adding computerized cognitive exercises to balance training improves balance and other recovery outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.